{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:50:07Z","timestamp":1782100207609,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["CRG\/2020\/000865"],"award-info":[{"award-number":["CRG\/2020\/000865"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar","award":["NPLC-AHP"],"award-info":[{"award-number":["NPLC-AHP"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/08\/2022-DDI\/BMS"],"award-info":[{"award-number":["45\/08\/2022-DDI\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Biotechnology","award":["BT\/PR62235\/MRNAR\/169\/15\/2025"],"award-info":[{"award-number":["BT\/PR62235\/MRNAR\/169\/15\/2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12010-026-05702-0","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:33:20Z","timestamp":1776224000000},"page":"5212-5230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering and Partial Characterization of an Anti-IL-23\/Anti-TNF-\u03b1 Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy"],"prefix":"10.1007","volume":"198","author":[{"family":"Sandeep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj H.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakeel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4145-539X","authenticated-orcid":false,"given":"Abhay H.","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"12","key":"5702_CR1","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., Miller, A. H., Mantovani, A., Weyand, C. M., Barzilai, N., Goronzy, J. J., Rando, T. A., Effros, R. B., Lucia, A., Kleinstreuer, N., & Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822\u20131832. https:\/\/doi.org\/10.1038\/s41591-019-0675-0","journal-title":"Nature Medicine"},{"key":"5702_CR2","doi-asserted-by":"publisher","unstructured":"Sandeep, Shinde, S. H., & Pande, A. H. (2023). Polyspecificity - An emerging trend in the development of clinical antibodies. Molecular immunology, 155, 175\u2013183. https:\/\/doi.org\/10.1016\/j.molimm.2023.02.005","DOI":"10.1016\/j.molimm.2023.02.005"},{"issue":"1","key":"5702_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024). NF-\u03baB in biology and targeted therapy: New insights and translational implications. Signal Transduction and Targeted Therapy, 9(1), Article 53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"5702_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12946","volume":"92","author":"LL Ten Bergen","year":"2020","unstructured":"Ten Bergen, L. L., Petrovic, A., Krogh Aarebrot, A., & Appel, S. (2020). The TNF\/IL-23\/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment. Scandinavian Journal of Immunology, 92(4), Article e12946. https:\/\/doi.org\/10.1111\/sji.12946","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1","key":"5702_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97236-0","volume":"11","author":"KJ Roberts","year":"2021","unstructured":"Roberts, K. J., Cubitt, M. F., Carlton, T. M., Rodrigues-Duarte, L., Maggiore, L., Chai, R., Clare, S., Harcourt, K., MacDonald, T. T., Ray, K. P., Vossenk\u00a8 amper, A., West, M. R., & Crowe, J. S. (2021). Preclinical development of a bispecific TNF\u03b1\/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. Scientific Reports, 11(1), Article 19422. https:\/\/doi.org\/10.1038\/s41598-021-97236-0","journal-title":"Scientific Reports"},{"issue":"3","key":"5702_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1636","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang, J., Kang, G., Lu, H., de Marco, A., Yuan, H., Feng, Z., Gao, M., Wang, X., Wang, H., Zhang, X., Wang, Y., Zhang, M., Wang, P., Feng, Y., Liu, Z., Cao, X., & Huang, H. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-\u03b1 and IL-23p19 bioactivities. Clinical and Translational Medicine, 14(3), Article e1636. https:\/\/doi.org\/10.1002\/ctm2.1636","journal-title":"Clinical and Translational Medicine"},{"key":"5702_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/12034754251316534","author":"MG Hren","year":"2025","unstructured":"Hren, M. G., & Khattri, S. (2025). Combining TNF-\u03b1 inhibitors with IL-4, IL-17, IL-23, or JAK inhibitors in patients with multiple, severe dermatologic conditions and\/or gastrointestinal or rheumatologic disease. Journal of Cutaneous Medicine and Surgery. https:\/\/doi.org\/10.1177\/12034754251316534","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"7","key":"5702_CR8","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1080\/09546634.2022.2095328","volume":"33","author":"B Strober","year":"2022","unstructured":"Strober, B., Armstrong, A., Rubant, S., Patel, M., Wu, T., Photowala, H., & Crowley, J. (2022). Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders. Journal of Dermatological Treatment, 33(7), 2991\u20132996. https:\/\/doi.org\/10.1080\/09546634.2022.2095328","journal-title":"Journal of Dermatological Treatment"},{"key":"5702_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1577628","volume":"16","author":"K Wang","year":"2025","unstructured":"Wang, K., Luo, H., Liu, L., Gao, H., Song, Y., & Li, D. (2025). Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis. Frontiers in Pharmacology, 16, Article 1577628. https:\/\/doi.org\/10.3389\/fphar.2025.1577628","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"5702_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2521082","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Zhao, X., Li, W., Sun, Y., & Liu, H. (2025). Switching biologic agent in patients with psoriasis: A systematic review and meta-analysis. Journal of Dermatological Treatment, 36(1), Article 2521082. https:\/\/doi.org\/10.1080\/09546634.2025.2521082","journal-title":"Journal of Dermatological Treatment"},{"issue":"47","key":"5702_CR11","doi-asserted-by":"publisher","first-page":"81860","DOI":"10.18632\/oncotarget.19899","volume":"8","author":"T Xu","year":"2017","unstructured":"Xu, T., Ying, T., Wang, L., Zhang, X. D., Wang, Y., Kang, L., Huang, T., Cheng, L., Wang, L., & Zhao, Q. (2017). A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A. Oncotarget, 8(47), 81860\u201381872. https:\/\/doi.org\/10.18632\/oncotarget.19899","journal-title":"Oncotarget"},{"issue":"2","key":"5702_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40259-019-00400-2","volume":"34","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q. (2020). Bispecific antibodies for autoimmune and inflammatory diseases: Clinical progress to date. BioDrugs\u202f: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 34(2), 111\u2013119. https:\/\/doi.org\/10.1007\/s40259-019-00400-2","journal-title":"BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy"},{"key":"5702_CR13","doi-asserted-by":"publisher","unstructured":"Sandeep, Shinde, S. H., Ahmed, S., Sharma, S. S., & Pande, A. H. (2024). Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology, 171(4), 464\u2013496. https:\/\/doi.org\/10.1111\/imm.13743","DOI":"10.1111\/imm.13743"},{"issue":"2","key":"5702_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2024.100258","volume":"4","author":"J Tietz","year":"2024","unstructured":"Tietz, J., Gunde, T., Warmuth, S., Weinert, C., Brock, M., Simonin, A., Hess, C., Johansson, M., Spiga, F., Muntwiler, S., Wickihalder, B., Mahler, D., Diem, D., Zeberer, J., Heiz, R., Fl\u00fcckiger, N., Shiraishi, N., Miyake, Y., Takahashi, N., \u2026 Snell, D. (2024). A bispecific, tetravalent antibody targeting inflammatory and pruritogenic pathways in atopic dermatitis. JID Innovations, 4(2), Article 100258. https:\/\/doi.org\/10.1016\/j.xjidi.2024.100258","journal-title":"JID Innovations"},{"key":"5702_CR15","doi-asserted-by":"publisher","unstructured":"Gala, C. K., Sandeep, Pande, A. H., & Sharma, S. S. (2025). Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-\u03b1. Pulmonary pharmacology & Therapeutics, 88, 102347. https:\/\/doi.org\/10.1016\/j.pupt.2025.102347","DOI":"10.1016\/j.pupt.2025.102347"},{"issue":"9","key":"5702_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-020-04510-5","volume":"26","author":"A Barkhordari","year":"2020","unstructured":"Barkhordari, A., Mahnam, K., & Mirmohammad-Sadeghi, H. (2020). Designing a new bispecific tandem single-chain variable fragment antibody against tumor necrosis factor-\u03b1 and interleukin-23 using in silico studies for the treatment of rheumatoid arthritis. Journal of Molecular Modeling, 26(9), Article 225. https:\/\/doi.org\/10.1007\/s00894-020-04510-5","journal-title":"Journal of Molecular Modeling"},{"key":"5702_CR17","doi-asserted-by":"publisher","unstructured":"Pande, A. H., Sandeep, & Shinde, S. H. (2024). Polybodies: Next-generation clinical antibodies. Drug Discovery Today, 29(12), 104198. https:\/\/doi.org\/10.1016\/j.drudis.2024.104198","DOI":"10.1016\/j.drudis.2024.104198"},{"issue":"1","key":"5702_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15321819.2020.1812640","volume":"42","author":"S Samavarchi Tehrani","year":"2021","unstructured":"Samavarchi Tehrani, S., Gharibi, S., Movahedpour, A., Goodarzi, G., Jamali, Z., Khatami, S. H., Maniati, M., Ranjbar, M., Shabaninejad, Z., Savardashtaki, A., & Taheri-Anganeh, M. (2021). Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: An in silico approach. Journal of Immunoassay & Immunochemistry, 42(1), 19\u201333. https:\/\/doi.org\/10.1080\/15321819.2020.1812640","journal-title":"Journal of Immunoassay & Immunochemistry"},{"issue":"7873","key":"5702_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., \u017d\u00eddek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., \u2026 Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"key":"5702_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.csbj.2022.12.021","volume":"21","author":"Z Bai","year":"2022","unstructured":"Bai, Z., Wang, J., Li, J., Yuan, H., Wang, P., Zhang, M., Feng, Y., Cao, X., Cao, X., Kang, G., de Marco, A., & Huang, H. (2022). Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations. Computational and Structural Biotechnology Journal, 21, 601\u2013613.","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"4","key":"5702_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","volume":"428","author":"GCP van Zundert","year":"2016","unstructured":"van Zundert, G. C. P., Rodrigues, J. P. G. L. M., Trellet, M., Schmitz, C., Kastritis, P. L., Karaca, E., Melquiond, A. S. J., van Dijk, M., de Vries, S. J., & Bonvin, A. M. J. J. (2016). The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. Journal of Molecular Biology, 428(4), 720\u2013725. https:\/\/doi.org\/10.1016\/j.jmb.2015.09.014","journal-title":"Journal of Molecular Biology"},{"issue":"5","key":"5702_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s10637-023-01387-y","volume":"41","author":"SS Jawalekar","year":"2023","unstructured":"Jawalekar, S. S., Kawathe, P. S., Sharma, N., Anakha, J., Tikoo, K., & Pande, A. H. (2023). Development and characterization of fused human arginase I for cancer therapy. Investigational New Drugs, 41(5), 652\u2013663. https:\/\/doi.org\/10.1007\/s10637-023-01387-y","journal-title":"Investigational New Drugs"},{"key":"5702_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.enzmictec.2023.110209","volume":"165","author":"P Dobariya","year":"2023","unstructured":"Dobariya, P., Adhya, P., Vaidya, B., Khandave, P. Y., Sharma, S. S., & Pande, A. H. (2023). Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning. Enzyme and Microbial Technology, 165, Article 110209. https:\/\/doi.org\/10.1016\/j.enzmictec.2023.110209","journal-title":"Enzyme and Microbial Technology"},{"issue":"1","key":"5702_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4274\/tjps.galenos.2022.47690","volume":"20","author":"D Demirhan","year":"2023","unstructured":"Demirhan, D. (2023). Stability evaluation of the biosimilar monoclonal antibody using analytical techniques. Turkish Journal of Pharmaceutical Sciences, 20(1), 48\u201357. https:\/\/doi.org\/10.4274\/tjps.galenos.2022.47690","journal-title":"Turkish Journal of Pharmaceutical Sciences"},{"key":"5702_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01361","volume":"8","author":"J Steven","year":"2017","unstructured":"Steven, J., M\u00fcller, M. R., Carvalho, M. F., Ubah, O. C., Kovaleva, M., Donohoe, G., Baddeley, T., Cornock, D., Saunders, K., Porter, A. J., & Barelle, C. J. (2017). In vitro maturation of a humanized shark VNAR domain to improve its biophysical properties to facilitate clinical development. Frontiers in Immunology, 8, Article 1361. https:\/\/doi.org\/10.3389\/fimmu.2017.01361","journal-title":"Frontiers in Immunology"},{"issue":"20","key":"5702_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205159","volume":"13","author":"J Panneerselvam","year":"2021","unstructured":"Panneerselvam, J., Madka, V., Rai, R., Morris, K. T., Houchen, C. W., Chandrakesan, P., & Rao, C. V. (2021). Inflammatory mediators and gut microbial toxins drive colon tumorigenesis by IL-23 dependent mechanism. Cancers, 13(20), Article 5159. https:\/\/doi.org\/10.3390\/cancers13205159","journal-title":"Cancers"},{"key":"5702_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.853008","volume":"13","author":"C Ishiwatari-Ogata","year":"2022","unstructured":"Ishiwatari-Ogata, C., Kyuuma, M., Ogata, H., Yamakawa, M., Iwata, K., Ochi, M., Hori, M., Miyata, N., & Fujii, Y. (2022). Ozoralizumab, a humanized anti-TNF\u03b1 NANOBODY\u00ae compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNF\u03b1 IgG. Frontiers in Immunology, 13, Article 853008. https:\/\/doi.org\/10.3389\/fimmu.2022.853008","journal-title":"Frontiers in Immunology"},{"key":"5702_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01614","volume":"10","author":"JF Silva","year":"2020","unstructured":"Silva, J. F., Olivon, V. C., Mestriner, F. L. A. C., Zanotto, C. Z., Ferreira, R. G., Ferreira, N. S., Silva, C. A. A., Luiz, J. P. M., Alves, J. V., Fazan, R., Cunha, F. Q., Alves-Filho, J. C., & Tostes, R. C. (2020). Acute increase in O-GlcNAc improves survival in mice with LPS-induced systemic inflammatory response syndrome. Frontiers in Physiology, 10, Article 1614. https:\/\/doi.org\/10.3389\/fphys.2019.01614","journal-title":"Frontiers in Physiology"},{"key":"5702_CR29","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/jitc-2023-SITC2023.1054","volume":"11","author":"Y Li","year":"2023","unstructured":"Li, Y., Feng, L., Feng, D., et al. (2023). 1054 Serum cytokine kinetics in C57BL\/6 versus BALB\/c mice upon Con A and LPS stimulation in vivo. Journal for ImmunoTherapy of Cancer, 11, 1054. https:\/\/doi.org\/10.1136\/jitc-2023-SITC2023.1054","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"5702_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01674-w","volume":"9","author":"R Hashimoto","year":"2023","unstructured":"Hashimoto, R., Koide, H., & Katoh, Y. (2023). MEK inhibitors increase the mortality rate in mice with LPS-induced inflammation through IL-12-NO signaling. Cell Death Discovery, 9(1), Article 374. https:\/\/doi.org\/10.1038\/s41420-023-01674-w","journal-title":"Cell Death Discovery"},{"issue":"1","key":"5702_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-07113-5","volume":"7","author":"LA Abriata","year":"2024","unstructured":"Abriata, L. A. (2024). The Nobel Prize in chemistry: Past, present, and future of AI in biology. Communications Biology, 7(1), Article 1409. https:\/\/doi.org\/10.1038\/s42003-024-07113-5","journal-title":"Communications Biology"},{"issue":"1","key":"5702_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/prot.26615","volume":"93","author":"CHM Rodrigues","year":"2025","unstructured":"Rodrigues, C. H. M., & Ascher, D. B. (2025). CSM-potential2: A comprehensive deep learning platform for the analysis of protein interacting interfaces. Proteins, 93(1), 209\u2013216. https:\/\/doi.org\/10.1002\/prot.26615","journal-title":"Proteins"},{"issue":"1","key":"5702_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-024-00668-2","volume":"25","author":"EK Oladipo","year":"2024","unstructured":"Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Omole, T. O., Adeyemo, S. F., Irewolede, B. A., Iwalokun, B. A., Ajani, O. F., & Onyeaka, H. (2024). Bioinformatics designing of an mRNA vaccine for Mokola virus (MOKV) using immunoinformatics as a secure strategy for successful vaccine development. BMC Immunology, 25(1), Article 77. https:\/\/doi.org\/10.1186\/s12865-024-00668-2","journal-title":"BMC Immunology"},{"key":"5702_CR34","doi-asserted-by":"publisher","first-page":"1647066","DOI":"10.3389\/fimmu.2025.1647066","volume":"16","author":"Pande AH, Sandeep, Anakha J (2026). Journey of therapeutic antibodies: from discovery to future. Explor Drug Sci. 2026;4:1008155.35. Alsayb M. A","year":"2025","unstructured":"Pande AH, Sandeep, Anakha J (2026). Journey of therapeutic antibodies: from discovery to future. Explor Drug Sci. 2026;4:1008155.35. Alsayb M. A. (2025). Innovations in immunotherapy for autoimmune diseases: Recent breakthroughs and future directions. Frontiers in Immunology, 16, 1647066. https:\/\/doi.org\/10.3389\/fimmu.2025.1647066","journal-title":"Frontiers in Immunology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05702-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:28:35Z","timestamp":1782098915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5702"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05702-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"9 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}